Neurodevelopmental Disorders in Children Exposed to Antipsychotic Medications During Pregnancy
Prenatal exposure to antipsychotic medications was not associated with increased risk of neurodevelopmental disorders in offspring.
Knowns and Unknowns About SSRI Use During Pregnancy in 2022
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on clinical issues regarding prescribing antidepressants during pregnancy with Ob.Gyn News on March 23, [...]
Essential Reads: Prenatal Valproate Exposure and Risk of Autism in Children
Prenatal exposure to valproic acid was associated with an increased risk of autism spectrum disorder in exposed children.
Language and Mathematical Skills in Danish Children with Prenatal Exposure to Antidepressants
Some studies have demonstrated associations between in utero exposure to antidepressants and cognitive outcomes.
Essential Reads: The Use of Trazodone During Pregnancy
More study is needed regarding the safety of sedative-hypnotic medications during pregnancy.
Reassuring News: Neurodevelopmental Outcomes in Two-Year Olds with Prenatal Exposure to Lamotrigine (Lamictal)
These findings are encouraging and suggest that the newer AEDs, specifically lamotrigine and levetiracetam, are not associated with worse neurodevelopmental outcomes.
Essential Reads: Long-Term Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antidepressants
While questions and controversies remain, the information on long-term neurodevelopmental outcomes in children prenatally exposed to antidepressants is largely reassuring.
Essential Reads: Lamotrigine (Lamictal) Dosing During Pregnancy
About 60% of women with mood disorders experience premenstrual exacerbation or PME of their mood during the premenstrual phase of their cycle.
Essential Reads – Psychotropic Treatment During Pregnancy: Research Synthesis and Clinical Care Principles
This review article provides clinically relevant data but also helps the reader navigate some of the more controversial issues in the field.   Â
Essential Reads: Duloxetine and Pregnancy (2021)
In this large study with over 1500 exposures, duloxetine exposure during the first trimester does not appear to increase risk of major malformations.